{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T09:44:00Z","timestamp":1784367840190,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"DOI":"10.1007\/s00432-025-06397-2","type":"journal-article","created":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T18:12:30Z","timestamp":1766427150000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Neoadjuvant SBRT and intraoperative electron radiotherapy in pancreatic cancer resection"],"prefix":"10.1007","volume":"152","author":[{"given":"Gianella","family":"Cornejo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Pikarsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayala","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Wygoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Skripai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aron","family":"Popovtzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Feldman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yair","family":"Hillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat","family":"Appelbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Temper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abed","family":"Khalaileh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Imam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gideon","family":"Zamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Blumenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,22]]},"reference":[{"issue":"22","key":"6397_CR1","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1200\/JCO.2016.67.5561","volume":"34","author":"EP Balaban","year":"2016","unstructured":"Balaban EP, Mangu PB, Khorana AA, Shah MA, Mukherjee S, Crane CH, Javle MM, Eads JR, Allen P, Ko AH, Engebretson A, Herman JM, Strickler JH, Benson AB 3rd, Urba S, Yee NS (2016) Locally advanced, unresectable pancreatic cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol 34(22):2654\u20132668","journal-title":"J Clin Oncol"},{"issue":"24","key":"6397_CR2","first-page":"4209","volume":"121","author":"S Cai","year":"2015","unstructured":"Cai S, Hong TS, Goldberg SI et al (2015) Updated long-term outcomes and prognostic factors for patients with unresectable locally advanced pancreatic cancer treated with intraoperative radiotherapy at MGH, 1978\u20132010. Cancer 121(24):4209\u20134217","journal-title":"Cancer"},{"issue":"23","key":"6397_CR3","first-page":"91","volume":"15","author":"FA Calvo","year":"2020","unstructured":"Calvo FA, Asencio JM, Roeder F, Krempien R, Poortmans P, Hensley FW, Krengli M (2020) ESTRO IORT Task Force\/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer. Clin Transl Radiat Oncol 15(23):91\u201399","journal-title":"Clin Transl Radiat Oncol"},{"key":"6397_CR4","first-page":"91","volume":"23","author":"FA Calvo","year":"2020","unstructured":"Calvo FA, Asencio JM, Roeder F et al (2020) ESTRO IORT task force\/ACROP recommendations for intraoperative radiation therapy in borderline-resected pancreatic cancer. Clin Transl Radiat Oncol 23:91\u201399","journal-title":"Clin Transl Radiat Oncol"},{"issue":"3","key":"6397_CR5","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.ijrobp.2013.02.022","volume":"86","author":"MD Chuong","year":"2013","unstructured":"Chuong MD, Springett GM, Freilich JM et al (2013) Stereotactic radiotherapy for locally advanced and borderline resectable pancreatic cancer is effective and well tolerated. Int J Radiat Oncol Biol Phys 86(3):516\u2013522","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"6397_CR6","first-page":"1234","volume":"42","author":"D Cunningham","year":"2024","unstructured":"Cunningham D, Chau I, Stocken DD et al (2024) Pancreatic adenocarcinoma: long-term outcomes of adjuvant therapy in the ESPAC4 phase III trial. J Clin Oncol 42(5):1234\u20131245","journal-title":"J Clin Oncol"},{"issue":"16_Suppl","key":"6397_CR7","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2024.42.16_suppl.4160","volume":"42","author":"P Ghaneh","year":"2024","unstructured":"Ghaneh P, Kleeff J, Halloran CM et al (2024) Impact of positive resection margins on recurrence and survival following resection and adjuvant chemotherapy in pancreatic cancer: results of the PRODIGE 24-CCTG PA-6 randomized controlled trial. J Clin Oncol 42(16_Suppl):4160","journal-title":"J Clin Oncol"},{"issue":"5","key":"6397_CR8","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","volume":"267","author":"VP Groot","year":"2018","unstructured":"Groot VP, Rezaee N, Wu W, Cameron JL, Fishman EK, Hruban RH, Weiss MJ, Zheng L, Wolfgang CL, He J (2018) Patterns, timing, and predictors of recurrence following pancreatectomy for pancreatic ductal adenocarcinoma. Ann Surg 267(5):936\u2013945","journal-title":"Ann Surg"},{"key":"6397_CR9","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1245\/s10434-019-08084-2","volume":"27","author":"JM Harrison","year":"2020","unstructured":"Harrison JM, Wo JY, Ferrone CR et al (2020) Intraoperative radiation therapy (IORT) for borderline resectable and locally advanced pancreatic ductal adenocarcinoma (BR\/LA PDAC) in the era of modern neoadjuvant treatment: short-term and long-term outcomes. Ann Surg Oncol 27:1400\u20131406","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"6397_CR10","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/cncr.29161","volume":"121","author":"JM Herman","year":"2015","unstructured":"Herman JM, Chang DT, Goodman KA et al (2015) Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma. Cancer 121(7):1128\u20131137","journal-title":"Cancer"},{"issue":"5","key":"6397_CR11","first-page":"1150","volume":"110","author":"JM Herman","year":"2024","unstructured":"Herman JM, Chang DT, Goodman KA et al (2024) Phase 2 study of stereotactic MR-guided adaptive radiation therapy (SMART) for pancreatic cancer: a multi-institutional trial. Int J Radiat Oncol Biol Phys 110(5):1150\u20131160","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"6397_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.prro.2022.01.005","volume":"12","author":"CS Hill","year":"2022","unstructured":"Hill CS, Fu W, Hu C, Sehgal S, Reddy AV, He J, Herman JM, Meyer JJ, Zaheer A, Narang AK (2022) Location, location, location: what should be targeted beyond gross disease for localized pancreatic ductal adenocarcinoma? Proposal of a standardized clinical tumor volume for pancreatic ductal adenocarcinoma of the head: the \u201cTriangle Volume.\u201d Pract Radiat Oncol 12(3):215\u2013225","journal-title":"Pract Radiat Oncol"},{"issue":"6","key":"6397_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/COC.0000000000000336","volume":"41","author":"FK Keane","year":"2018","unstructured":"Keane FK, Wo JY, Ferrone CR et al (2018) Intraoperative radiotherapy in the era of intensive neoadjuvant chemotherapy and chemoradiotherapy for pancreatic adenocarcinoma. Am J Clin Oncol 41(6):607\u2013612","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"6397_CR14","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ijrobp.2015.12.003","volume":"94","author":"S Krishnan","year":"2016","unstructured":"Krishnan S, Chadha AS, Suh Y, Chen HC, Rao A, Das P, Minsky BD, Mahmood U, Delclos ME, Sawakuchi GO, Beddar S, Katz MH, Fleming JB, Javle MM, Varadhachary GR, Wolff RA, Crane CH (2016) Focal radiation therapy dose escalation improves overall survival in locally advanced pancreatic cancer patients receiving induction chemotherapy and consolidative chemoradiation. Int J Radiat Oncol Biol Phys 94(4):755\u2013765","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10242","key":"6397_CR15","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","volume":"395","author":"JD Mizrahi","year":"2020","unstructured":"Mizrahi JD, Surana R, Valle JW, Shroff RT (2020) Pancreatic cancer. Lancet 395(10242):2008\u20132020","journal-title":"Lancet"},{"issue":"9","key":"6397_CR16","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1001\/jama.2021.13027","volume":"326","author":"W Park","year":"2021","unstructured":"Park W, Chawla A, O\u2019Reilly EM (2021) Pancreatic cancer: a review. JAMA 326(9):851\u2013862","journal-title":"JAMA"},{"issue":"9","key":"6397_CR17","doi-asserted-by":"publisher","first-page":"2584","DOI":"10.3390\/cancers15092584","volume":"15","author":"M S\u0142odkowski","year":"2023","unstructured":"S\u0142odkowski M, Wro\u0144ski M, Karkocha D, Kraj L, \u015amigielska K, Jachnis A (2023) Current approaches for the curative-intent surgical treatment of pancreatic ductal adenocarcinoma. Cancers (Basel) 15(9):2584","journal-title":"Cancers (Basel)"},{"issue":"5","key":"6397_CR18","first-page":"1004","volume":"11","author":"H Teng","year":"2020","unstructured":"Teng H, Zhang J, Bao Y et al (2020) Dosimetric feasibility on hypofractionated intensity-modulated radiotherapy and simultaneous integrated boost for locally advanced unresectable pancreatic cancer with helical tomotherapy. J Gastrointest Oncol 11(5):1004\u20131012","journal-title":"J Gastrointest Oncol"},{"issue":"11","key":"6397_CR19","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1200\/JCO.21.02233","volume":"40","author":"E Versteijne","year":"2022","unstructured":"Versteijne E, van Dam JL, Suker M, Janssen QP, Groothuis K, Akkermans-Vogelaar JM, Besselink MG, Bonsing BA, Buijsen J, Busch OR, Creemers GM, van Dam RM, Eskens FALM, Festen S, de Groot JWB, Groot Koerkamp B, de Hingh IH, Homs MYV, van Hooft JE, Kerver ED, Luelmo SAC, Neelis KJ, Nuyttens J, Paardekooper GMRM, Patijn GA, van der Sangen MJC, de Vos-Geelen J, Wilmink JW, Zwinderman AH, Punt CJ, van Tienhoven G, van Eijck CHJ, Dutch Pancreatic Cancer Group (2022) Neoadjuvant chemoradiotherapy versus upfront surgery for resectable and borderline resectable pancreatic cancer: long-term results of the dutch randomized PREOPANC trial. J Clin Oncol 40(11):1220\u20131230","journal-title":"J Clin Oncol"},{"issue":"1","key":"6397_CR20","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/COC.0000000000000472","volume":"42","author":"NG Zaorsky","year":"2019","unstructured":"Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE (2019) Dose escalation in stereotactic body radiation therapy for pancreatic cancer: a meta-analysis. Am J Clin Oncol 42(1):46\u201355","journal-title":"Am J Clin Oncol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06397-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-025-06397-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-025-06397-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T08:02:25Z","timestamp":1766476945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-025-06397-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,22]]},"references-count":20,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1]]}},"alternative-id":["6397"],"URL":"https:\/\/doi.org\/10.1007\/s00432-025-06397-2","relation":{},"ISSN":["1432-1335"],"issn-type":[{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,22]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"19"}}